By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



30 Worcester Road

Toronto  Ontario  M9W 5X2  Canada
Phone: 416-798-3001 Fax: 416-798-3007



Company News
IntelliPharmaCeutics Announces Second Quarter 2016 Results 7/13/2016 8:15:58 AM
IntelliPharmaCeutics Reports Update On Rexista XR: FDA Grants Waiver Of NDA Filing Fee, And Topline Pharmacokinetics Results Indicate No Food Effect 7/5/2016 10:43:02 AM
IntelliPharmaCeutics Announces Pricing Of $5.2 Million Public Offering Of Common Shares And Warrants 5/27/2016 8:19:54 AM
IntelliPharmaCeutics Announces FDA Approval For 500 Mg And 750 Mg Generic Keppra XR® 2/25/2016 9:37:05 AM
IntelliPharmaCeutics To Present At The Biotech Showcase 12/22/2015 11:51:04 AM
IntelliPharmaCeutics To Present At The LD Micro Main Event 11/25/2015 7:45:24 AM
IntelliPharmaCeutics To Present At The Microcap Conference 10/27/2015 7:46:17 AM
IntelliPharmaCeutics To Present At Dawson James Securities Growth Stock Conference 10/9/2015 7:25:21 AM
IntelliPharmaCeutics Announces Third Quarter 2015 Results 10/9/2015 7:24:14 AM
IntelliPharmaCeutics Updates Status Of Tentative Approvals Of Generic Focalin XR 8/5/2015 7:23:42 AM